BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang C, Yu S, Zhang Y, Zhang M, Lv L, Huang C, Li X, Li J, Zhang Z. Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy. Exp Ther Med 2019;17:2473-84. [PMID: 30906435 DOI: 10.3892/etm.2019.7255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Dolati F, Behboudi E, Naderi M, Shahramian I, Moradi A, Department of Microbiology, Damqan University of Medical Sciences, Damqan, Iran, Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran, Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran, Department of Pediatric, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran, Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran. Evaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients. Iran J Med Microbiol 2022;16:66-75. [DOI: 10.30699/ijmm.16.1.66] [Reference Citation Analysis]
2 Wang R, Xie Z. A Simple and Rapid Method for Quantitative Detection of Hepatitis B Virus Drug-resistant Mutations. J Clin Transl Hepatol 2021;9:139-40. [PMID: 34007793 DOI: 10.14218/JCTH.2021.00135] [Reference Citation Analysis]
3 Mandary MB, Masomian M, Poh CL. Impact of RNA Virus Evolution on Quasispecies Formation and Virulence. Int J Mol Sci 2019;20:E4657. [PMID: 31546962 DOI: 10.3390/ijms20184657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
4 Adefovir-dipivoxil/lamivudine. Reactions Weekly 2019;1750:20-20. [DOI: 10.1007/s40278-019-60884-5] [Reference Citation Analysis]